Antisense modulation of PTP1B expression

Details Antisense modulation of PTP1B expression Antisense modulation of PTP1B expression

2007-02-20

2007-02-20

Zara, Jane (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C435S006120, C435S091100, C435S091310, C435S455000, C435S458000, C536S023100, C536S024300, C536S024500

Reexamination Certificate

active

10360510

ABSTRACT:
Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.

REFERENCES:
patent: 5726027 (1998-03-01), Olefsky
patent: 5801154 (1998-09-01), Baracchini
patent: 6261840 (2001-07-01), Cowsert et al.
patent: 6261849 (2001-07-01), Lee
patent: 6506559 (2003-01-01), Fire et al.
patent: 6602857 (2003-08-01), Cowsert et al.
patent: 2003/0220282 (2003-11-01), Bhanot et al.
patent: WO 97/32595 (1997-09-01), None
patent: WO-97/32595 (1997-09-01), None
patent: WO 01/53528 (2001-07-01), None
patent: WO-01/53528 (2001-07-01), None
patent: WO 02/10378 (2002-02-01), None
patent: WO 02/092772 (2002-11-01), None
patent: PCT-WO 03/070881 (2003-08-01), None
patent: PCT-WO 03/099227 (2003-12-01), None
C. Arregui et al, “Impaired Integrin-mediated Adhesion and Signaling in Fibroblasts Expressing a Dominant-negative Mutant PTP1B”, J. Cell Biol., 143(3):861-873 (Nov. 2, 1998).
J. Balsamo et al, “The Nonreceptor Protein Tyrosine Phosphatase PTP1B Binds to the Cytoplasmic Domain of N-Cadherin and Regulates the Cadherin-Actin Linkage”, J.Cell Biol., 143(2):523-532 (Oct. 19, 1998).
A. Branch, “A Good Antisense Molecule is Hard to Find”, TIBS, 23:45-50 (Feb. 1998).
S. Brown-Shimer et al, “Effect of Protein Tyrosine Phosphatase 1B Expression on Transformation by the Human neu Oncogene”, Cancer Res., 52:478-482 (Jan. 15, 1992).
H. Chen et al. “A Phosphotyrosyl Mimetic Peptide Reverses Impairment of Insulin-Stimulated Translocation of GLUT4 Caused by Overexpression of PTP1B in Rat Adipose Cells”, Biochemistry, 38(1):384-389 (Jan. 5, 1999).
H. Chen et al, “Protein-Tyrosine Phosphatases PTP1B and Syp Are Modulators of Insulin-stimulated Translocation of GLUT4 in Transfected Rat Adipose Cells”, J. Biol. Chem., 272(12):8026-8031 (Mar. 21, 1997).
J. Chernoff et al, “Cloning of a cDNA for a Major Human Protein-Tyrosine-Phosphatase”, Proc. Natl. Acad. Sci. USA, 87:2735-2739 (Apr. 1990).
S. Crooke, “Basic Principles of Antisense Therapeutics” in Antisense Research and Application, Chapter 1, pp. 1-50 (Springer-Verlag Berlin Heidelberg 1998).
R. Crystal, “Transfer of Genes to Humans: Early Lessons and Obstacles to Success”, Science, 270:404-410 (Oct. 20, 1995).
S. Desmarais et al, “Inhibition of Protein Tyrosine Phosphatases PTP1B and CD45 by Sulfotyrosyl Peptides”, Arch. Biochem. Biophys., 354(2):225-231 (Jun. 15, 1998).
M. Elchebly et al, “Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the Protein Tyrosine Phosphatase-1B Gene”, Science, 283:1544-1548 (Mar. 5, 1999).
D. Ferber, “Cell Biology: New Clues Found to Diabetes and Obesity”, Science, 283(5407):1423-1425 (Mar. 5, 1999).
T. Friedmann, “Overcoming the Obstacles—Treating Disease by Providing Needed Genes Remains a Compelling Idea, But Clinical and Basic Researchers Still Have Much to do Before Gene Therapy Can Live Uo to its Promise”, Scientific American, pp. 96-101 (Jun. 1997).
B. Goldstein et al, “Regulation of the Insulin Signalling Pathway by Cellular Protein-Tyroine Phosphatases”, Molecular and Cellular Biochemistry, 182:91-99 (May 1998).
S. Ham et al, “Selective Inactivation of Protein Tyrosine Phosphatase PTP1B by Sulfone Analogue of Naphthoquinone”, Bioorganic & Medical Chemistry Letters, 9:185-186 (Jan. 18, 1999).
A. Hassid et al, “Antisense Oligonucleotides Against Protein Tyrosine Phosphatase 1B Increase Focal Adhesion Protein Phosphorylation and Migration in Rat Aortic Smooth Muscle Cells”, in Supplement to Circulation, Journal of the American Heart Association, Abstracts from 71stScientific Sessions, Dallas Convention Center, Dallas, Texas, Supplement I, Abstract No. 1733 (Nov. 8-11, 1998).
S. Huang et al, “Antisense to Protein Tyrosine Phosphatase 1B Increases Tyrosine Phosphorylation of Focal Adhesion Protein in Aortic Smooth Muscle Cells of Rats”, FASEB Journal, 12(4):A188, Abstract No. 1099 (Mar. 1998).
W. James, “Towards Gene-Inhibition Therapy: A Review of Progress and Prospects in the Field of Antiviral Antisense Nucleic Acids and Ribozymes”, Antiviral Chemistry & Chemotherapy, 2(4):191-214 (1991).
K. Lamontagne et al, “Protein Tyrosine Phosphatase PTP1B Suppresses p210 bcr-abl-induced Transformation of Rat-1 Fibroblasts and Promotes Differentiation of K562 Cells”, Proc. Natl. Acad. Sci. USA, 95:14094-14099 (Nov. 1998).
S-R. Lee et al, “Reversible Inactivation of Protein-Tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor”, J. Biol. Chem., 273(25):15366-15372 (Jun. 19, 1998).
F. Liu et al, “Protein Tyrosine Phosphatase 1B Interacts with and is Tyrosine Phosphorylated by the Epidermal Growth Factor Receptor”, Biochem J., 327:139-145 (Oct. 1, 1997).
F. Liu et al, “Protein Tyrosine Phosphatase 1B Negatively Regulates Integrin Signaling”, Current Biology, 8:173-176 (Jan. 19, 1998).
F. Liu et al, “Transformation Suppression by Protein Tyrosine Phosphatase 1B Requires a Functional SH3 Ligand”, Mol. Cell. Biol., 18(1):250-259 (Jan. 1998).
N. Milner et al, “Selecting Effective Antisense Reagents on Combinatorial Oligonucleotide Arrays”, Nature Biotechnology, 15:537-541 (Jun. 1997).
G. Palu et al, “In Pursuit of New Development for Gene Therapy of Human Diseases”, J. Biotech., 68:1-13 (Feb. 5, 1999).
K. Pihl-Carey, “Isis to Restructure as Crohn's Diseases Drug Fails in Phase III”, in The Daily Biotechnology Newspaper, 10(239):1-2 (Dec. 15, 1999).
P. Roller et al, “Potent Inhibition of Protein-Tyrosine Phosphatase-1B Using the Phosphotyrosyl Mimetic Fluoro-O-Malonyl Tyrosine (FOMT)”, Bioorganic & Medical Chemistry Letters, 8:2149-2150 (Aug. 18, 1998).
A. Schievella et al, “Protein Tyrosine Phosphastase 1B Undergoes Mitosis-specific Phosphorylation on Serine”, Cell Growth & Differentiation, 4:239-246 (Apr. 1993).
J. Schofield et al, “Non-Viral Approaches to Gene Therapy”, British Medical Bulletin, 51(1):56-71 (1995).
B. Seely et al, “Protein Tyrosine Phosphatase 1B Interacts with the Activated Insulin Receptor”, Diabetes, 45:1379-1385 (Oct. 1996).
S. Sell et al, “Insulin-Inducible Changes in the Relative Ratio of PTP1B Splice Variants”, Molecular Genetics and Metabolism, 66:189-192 (Mar. 1999).
V. Shifrin et al, “Growth Factor-Inducible Alternative Splicing of Nontransmembrane Phosphotyrosine Phosphatase PTP-1B Pre-mRNA”, J. Biol. Chem., 268(34):25376-25384 (Dec. 5, 1993).
K. Skorey et al, “How Does Alendronate Inhibit Protein-tyrosine Phosphatases”, J. Biol. Chem., 272(36):22472-22480 (Sep. 5, 1997).
M. Taing et al, “Potent and Highly Selective Inhibitors of the Protein Tyrosine Phosphatase 1B”, Biochemistry, 38:3793-3803 (Mar. 23, 1999).
S. Taylor et al, “Potent Non-peptidyl Inhibitors of Protein Tyrosine Phosphatase 1B”, Bioorganic & Medicinal Chemistry, 6:1457-1468 (Sep. 6, 1998).
N. Tonks et al, “Characterization of the Major Protein-Tyrosine-Phosphatases of Human Placenta”, J. Biol. Chem., 263(14):6731-6737 (May 15, 1988).
N. Tonks et al, “Purification of the Major Protein-Tyrosine-Phosphatases of Human Placenta”, J. Biol. Chem., 263(14):6722-6730 (May 15, 1988).
I. Verma et al, “Gene Therapy—Promises, Problems and Prospects”, Nature 389:239-242 (Sep. 18, 1997).
Q Wang et al, “Naphthalenebis[α,α-Difluoromethylenephosphonates] as Potent Inhibitors of Protein Tyrosine Phosphatases”, Bioorganic & Medical Chemis

Affiliated with

Also associated with

Rating

Antisense modulation of PTP1B expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of PTP1B expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of PTP1B expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3842250